Spyre Therapeutics (SYRE) Exchange Rate Effect (2020 - 2024)
Spyre Therapeutics (SYRE) reported Exchange Rate Effect of -$15000.0 for Q4 2024, down 183.33% on a YoY basis from $18000.0 in Q1 2024, and down 193.75% quarter-over-quarter from $16000.0 in Q3 2024.
Spyre Therapeutics (SYRE) Exchange Rate Effect (2020 - 2024) Analysis & Trends
Spyre Therapeutics has reported Exchange Rate Effect for 5 years, with the latest figure at -$15000.0 in Q4 2024.
- For the quarter ending Q4 2024, Exchange Rate Effect fell 183.33% year-over-year to -$15000.0; the trailing twelve-month figure through Sep 2025 stood at -$15000.0 (down 150.0% YoY), and the FY2024 full-year result was -$3000.0, down 112.0% from the prior year.
- Exchange Rate Effect for Q4 2024 stood at -$15000.0, down from $16000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $47000.0 in Q4 2020, with the low at -$72000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged -$3250.0 across 5 years, with a median of $3500.0 in 2021.
- The largest YoY upside for Exchange Rate Effect was 1433.33% in 2022 against a maximum downside of 1900.0% in 2022.
- Spyre Therapeutics' Exchange Rate Effect stood at $47000.0 in 2020, then slumped by 93.62% to $3000.0 in 2021, then surged by 1433.33% to $46000.0 in 2022, then plunged by 60.87% to $18000.0 in 2023, then tumbled by 183.33% to -$15000.0 in 2024.
- The last three Exchange Rate Effect figures came in at -$15000.0 (Q4 2024), $16000.0 (Q3 2024), and -$4000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Spyre Therapeutics | 6.95 Bn | 6.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -15,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | -17,000.00 |
| Sep 30, 2023 | -17,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Dec 31, 2022 | 46,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -72,000.00 |
| Jun 30, 2022 | -72,000.00 |